Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

SVB Leerink Maintains Market Perform on AMAG Pharmaceuticals, Raises Price Target to $13.65

Author: Benzinga Newsdesk | October 02, 2020 04:36am
SVB Leerink analyst Ami Fadia maintains AMAG Pharmaceuticals (NASDAQ:AMAG) with a Market Perform and raises the price target from $10 to $13.65.

Posted In: AMAG